8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-25-081924
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading tm2524070d1_8k.htm…